[Recent aspects of vitamin E in pediatrics].
New aspects of vitamin E metabolism have demonstrated new indications for its use in pediatrics. With respect to the retrolental fibroplasia of prematures under intensive care it can be stated that vitamin E does not necessarily prevent this complication but surely can decrease its severity. For the intensive care of newborns it is of importance that vitamin E is apparently able to decrease the frequency of intraventricular hemorrhage. The effect of vitamin E on the metabolism of prostaglandins opens new insights in the understanding of thrombocyte aggregation and atherogenesis. There may be a possible indication for the substitution of vitamin E in patients with diabetes mellitus type I.
D000818:Animals; D001692:Biological Transport; D001997:Bronchopulmonary Dysplasia / Q000188:drug therapy; D002543:Cerebral Hemorrhage / Q000188:drug therapy; D002552:Cerebral Ventricles; D006801:Humans; D007227:Infant Nutritional Physiological Phenomena; D007231:Infant, Newborn; D007234:Infant, Premature; D007567:Jaundice, Neonatal / Q000188:drug therapy; D009359:Neonatology; D009422:Nervous System Diseases / Q000209:etiology; D011453:Prostaglandins / Q000378:metabolism; D011485:Protein Binding; D051381:Rats; D012178:Retinopathy of Prematurity / Q000188:drug therapy; D014810:Vitamin E / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D014811:Vitamin E Deficiency / Q000150:complications / Q000378:metabolism
D011453:Prostaglandins; D014810:Vitamin E
Neuere Aspekte von Vitamin E für die Kinderheilkunde.